Enable unparalleled data-driven insights for COVID-19 testing and drug development. Our Labcorp de-identified test results help you be responsive and nimble in a shifting patient landscape. The data is refreshed and uploaded daily so we can identify patient clusters, anticipate the next hot spot and help you refine your COVID-19 recruitment strategies.
Apply our past experience running challenging pneumonia studies with intubated patients and designing protocols that are optimized for patient recruitment and retention.
Access a dedicated and highly coordinated COVID-19 Response Team that will help connect you to the right people and support any expedited drug development needs due to the urgency of the global pandemic
Design patient-centric protocols around actual feedback from patients to improve recruitment and retention. Select the most productive and experienced sites leveraging our investigator recruitment performance data derived from over 50% of all global industry sponsored trials.
Add hybrid elements to the traditional clinical trial model, such as eConsent, ePRO, eCOA and telemedicine technology, that together with our U.S.-based patient services centers and global home health services, can reduce the frequency of on-site visits and gather valuable patient data to inform decision making.
Stay nimble and quickly react to changing landscapes. We can empower your trial with valuable data:
Improve patient enrollment and retention while reducing the frequency of on-site visits and gather valuable patient data to inform decision making. Together, we can enable focused, efficient COVID-19 clinical trials.
Connect with our COVID-19 Response Team
Contact Us
Labcorp is a leading global life sciences company that includes contract research and developmental services to the pharmaceutical, medical technology, crop protection and chemical industries.
.png){kind=icon}